BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Advances in Genome Sequencing could Further Precision Cancer Therapies

  At the Advances in Genome Biology and Technology general meeting, innovators from industry and academia discuss how recent advances in whole genome sequencing are propelling cancer research.

  February 7, 2023

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Novel Alliance Responds to Big Pharma’s Most Pressing AI/ML Needs

  AI/ML applications are being deployed at large pharmaceutical companies, but in order to truly maximize their potential, better infrastructure is needed. AION Labs believes it is answering that call.

  February 7, 2023

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Roche Goes Toe-to-Toe with AstraZeneca’s Soliris in PNH

  Data from a Phase III study show Genentech’s crovalimab is non-inferior to AstraZeneca’s Soliris, the current standard of care in paroxysmal nocturnal hemoglobinuria (PNH).

  February 7, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Business

  Signs Layoffs may be Coming Soon at Your Job

  Though there is no sure-fire tell, there are a few signs to look out for that indicate leadership could be planning to cut staff. Here are the signs layoffs may be coming soon at your organization.

  February 7, 2023

   · 

  3 min read

   · 

  Rosemary Scott
• 

  Business

  Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda

  Merck and Nectin Therapeutics announced a research collaboration agreement to study the safety and efficacy of Nectin’s investigational antibody in locally advanced and metastatic solid tumors.

  February 7, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug Development

  Dragonfly Welcomes BMS-Dropped IL-12 Asset Back into the Fold (Updated)

  Bristol Myers Squibb has returned the rights for interleukin-12 immunotherapy program DF6002 back to its original owner, Dragonfly Therapeutics, the companies announced Monday.

  February 7, 2023

   · 

  1 min read

   · 

  Rosemary Scott
• Innate Pharma to Participate in Upcoming Investor Conferences - February 07, 2023

  Innate Pharma SA announced that members of its senior management team are scheduled to participate in the following upcoming investor conferences.

  February 7, 2023

   · 

  3 min read
• Business

  Keyron appoints new Chief Executive Officer

  Keyron, the medical technology group focused on reversing type 2 diabetes, non-alcoholic steatohepatitis, and obesity via an innovative medical device platform, announced the appointment of Carl D Francis as Chief Executive Officer.

  February 7, 2023

   · 

  3 min read
• GN expands groundbreaking ReSound OMNIA family enabling more people to hear their best in noise

  GN Hearing, the global leader in hearing aid innovation, announces the expansion of the popular ReSound OMNIA family, providing more options to address the biggest unmet need for people with hearing loss: hearing speech in noisy environments.

  February 7, 2023

   · 

  4 min read
• Business

  Haemonetics 3rd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

  Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal 2023, which ended December 31, 2022, are available on its Investor Relations website.

  February 7, 2023

   · 

  2 min read